155 related articles for article (PubMed ID: 14502504)
1. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks.
Murcia-Soler M; Pérez-Giménez F; García-March FJ; Salabert-Salvador MT; Díaz-Villanueva W; Castro-Bleda MJ
J Chem Inf Comput Sci; 2003; 43(5):1688-702. PubMed ID: 14502504
[TBL] [Abstract][Full Text] [Related]
2. Artificial neural networks and linear discriminant analysis: a valuable combination in the selection of new antibacterial compounds.
Murcia-Soler M; Pérez-Giménez F; García-March FJ; Salabert-Salvador MT; Díaz-Villanueva W; Castro-Bleda MJ; Villanueva-Pareja A
J Chem Inf Comput Sci; 2004; 44(3):1031-41. PubMed ID: 15154772
[TBL] [Abstract][Full Text] [Related]
3. A scoring scheme for discriminating between drugs and nondrugs.
Sadowski J; Kubinyi H
J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
[TBL] [Abstract][Full Text] [Related]
4. Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures.
Niwa T
J Chem Inf Comput Sci; 2003; 43(1):113-9. PubMed ID: 12546543
[TBL] [Abstract][Full Text] [Related]
5. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
Ajay A; Walters WP; Murcko MA
J Med Chem; 1998 Aug; 41(18):3314-24. PubMed ID: 9719583
[TBL] [Abstract][Full Text] [Related]
6. A neural network based classification scheme for cytotoxicity predictions:Validation on 30,000 compounds.
Molnár L; Keseru GM; Papp A; Lorincz Z; Ambrus G; Darvas F
Bioorg Med Chem Lett; 2006 Feb; 16(4):1037-9. PubMed ID: 16288868
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural networks analysis used to evaluate the molecular interactions between selected drugs and human alpha1-acid glycoprotein.
Buciński A; Wnuk M; Goryński K; Giza A; Kochańczyk J; Nowaczyk A; Baczek T; Nasal A
J Pharm Biomed Anal; 2009 Nov; 50(4):591-6. PubMed ID: 19117712
[TBL] [Abstract][Full Text] [Related]
8. Comparison of support vector machine and artificial neural network systems for drug/nondrug classification.
Byvatov E; Fechner U; Sadowski J; Schneider G
J Chem Inf Comput Sci; 2003; 43(6):1882-9. PubMed ID: 14632437
[TBL] [Abstract][Full Text] [Related]
9. Model-free drug-likeness from fragments.
Ursu O; Oprea TI
J Chem Inf Model; 2010 Aug; 50(8):1387-94. PubMed ID: 20726597
[TBL] [Abstract][Full Text] [Related]
10. "In-house likeness": comparison of large compound collections using artificial neural networks.
Muresan S; Sadowski J
J Chem Inf Model; 2005; 45(4):888-93. PubMed ID: 16045282
[TBL] [Abstract][Full Text] [Related]
11. Classification of dopamine antagonists using TFS-based artificial neural network.
Fujishima S; Takahashi Y
J Chem Inf Comput Sci; 2004; 44(3):1006-9. PubMed ID: 15154769
[TBL] [Abstract][Full Text] [Related]
12. Predicting blood-brain barrier penetration of drugs using an artificial neural network.
Fu XC; Wang GP; Liang WQ; Yu QS
Pharmazie; 2004 Feb; 59(2):126-30. PubMed ID: 15025181
[TBL] [Abstract][Full Text] [Related]
13. Predictive activity profiling of drugs by topological-fragment-spectra-based support vector machines.
Kawai K; Fujishima S; Takahashi Y
J Chem Inf Model; 2008 Jun; 48(6):1152-60. PubMed ID: 18533712
[TBL] [Abstract][Full Text] [Related]
14. In silico log P prediction for a large data set with support vector machines, radial basis neural networks and multiple linear regression.
Chen HF
Chem Biol Drug Des; 2009 Aug; 74(2):142-7. PubMed ID: 19549084
[TBL] [Abstract][Full Text] [Related]
15. ANN-QSAR model of drug-binding to human serum albumin.
Deeb O; Hemmateenejad B
Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
[TBL] [Abstract][Full Text] [Related]
16. Descriptors, physical properties, and drug-likeness.
Brüstle M; Beck B; Schindler T; King W; Mitchell T; Clark T
J Med Chem; 2002 Aug; 45(16):3345-55. PubMed ID: 12139446
[TBL] [Abstract][Full Text] [Related]
17. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks.
Barron L; Havel J; Purcell M; Szpak M; Kelleher B; Paull B
Analyst; 2009 Apr; 134(4):663-70. PubMed ID: 19305914
[TBL] [Abstract][Full Text] [Related]
18. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
19. Prediction of auto-ignition temperatures of hydrocarbons by neural network based on atom-type electrotopological-state indices.
Pan Y; Jiang J; Wang R; Cao H; Zhao J
J Hazard Mater; 2008 Sep; 157(2-3):510-7. PubMed ID: 18280036
[TBL] [Abstract][Full Text] [Related]
20. Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds.
Karakoc E; Sahinalp SC; Cherkasov A
J Chem Inf Model; 2006; 46(5):2167-82. PubMed ID: 16995747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
